Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Fixed Capital/Sales

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

CONCORD BIOTECH Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.800.800.890.940.76

What is the latest Fixed Capital/Sales ratio of CONCORD BIOTECH ?

The latest Fixed Capital/Sales ratio of CONCORD BIOTECH is 0.80 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.80
Mar20240.80
Mar20230.89
Mar20220.94
Mar20210.76

How is Fixed Capital/Sales of CONCORD BIOTECH Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.8
0.00
Mar2024 0.8
-10.11
Mar2023 0.89
-5.32
Mar2022 0.94
23.68
Mar2021 0.76 -

Other Financial Ratios of CONCORD BIOTECH


Compare Fixed Capital/Sales ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹10,873.7 Cr -9.1% -5.6% -37.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,645.0 Cr -1.5% 1.6% 1.3% Stock Analytics
DIVIS LABORATORIES ₹159,625.0 Cr -2% -4.3% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,415.0 Cr -0.8% 0.5% 32% Stock Analytics
DR REDDYS LABORATORIES ₹108,664.0 Cr -2.7% -1.6% 6.9% Stock Analytics
CIPLA ₹100,480.0 Cr -3.9% -9.1% -18.4% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-9.1%

-5.6%

-37.3%

SENSEX

-1.9%

-9.1%

-0.2%


You may also like the below Video Courses